Patients

Achieving and Maintaining Improved Quality of Life in Patients with Tardive Dyskinesia

10/15/2020

Popular Now

In-depth Discussion about Deutetrabenazine and Valbenazine

Videos

In-depth Discussion about Deutetrabenazine and Valbenazine

01/24/2019

Drs. Jain and Kumar provide and in-depth analysis of two new VMAT2 inhibitors approved to treat tardive dyskinesia.

Drs. Jain and Kumar provide and...

01/24/2019

Psychiatry & Behavioral Health

News

Study: 60% of Residential Programs Offer No MOUDs

08/04/2020

Medication-assisted treatment is referred to by many within the field as the “gold standard,” but a study published on JAMA Network Open in July shows that use of medications for opioid use disorder (MOUD) is anything but standard at...

Medication-assisted treatment is...

08/04/2020

Addiction Professional

Quiz

Quiz: TD Guidelines and Diagnostic Criteria

05/27/2021

Psychiatry & Behavioral Health

News

Adverse Events With Deutetrabenazine Titration Decrease During Maintenance

06/15/2021

Adverse events in patients treated with deutetrabenazine were more common during titration than maintenance, a finding that provides “important context for the dosing schedule to providers and patients.” Researchers reported on safety and...

Adverse events in patients...

06/15/2021

Psychiatry & Behavioral Health

Q&A

Clinicians Should Set Realistic Expectations for Telehealth Treatment

06/28/2021

Onboarding patients to telepsychiatry includes setting realistic expectations for both the patient and provider and ensuring the patient is comfortable with the platform, says Edward Kaftarian, MD.

Achieving and Maintaining Improved Quality of Life in Patients with Tardive Dyskinesia

Popular Now

Sign Up

Specialties

Events

Year Round Education

HMP Global Products